Category - Pharmaceutical Industry

• FDA OKs bladder cancer treatment by L.A.-area firm
• States want to make it harder for health insurers to deny care
• Study: Hospitaliz­ed patients do better with female doctors
• Why PMBs are hurting health care
• Drop in Chronic Kidney Disease in Type 2 Diabetes seen with new drug
• New clinical trials recruitmen­t model powered by AI, blockchain launched in PHL
• Four changes in 2024 that could reshape US health care
• Medicare’s push to improve chronic care attracts businesses, but not many doctors
• Healthway Cancer Care Hospital offers world-class cancer care at affordable prices
• Register for NMS now
• 2 Filipino pharma companies win healthcare awards in Singapore
• Missouri, don’t make abuse in rural drug program even worse
• Governor’s drug affordabil­ity board veto serves cancer patients
• Government fails to get life-saving insulin pens for diabetics
• Govt expands panel to reform drug, device price mechanism
• Asda is first UK store to launch an online prescripti­on service
• ‘Pharmacy deserts’ spreading across Pennsylvan­ia
• Ozempic babies spark debate about weight-loss shot use as fertility drugs
• More than 900 people waited over 12 hours at area’s A&Es in March
• The time for words is over. We need action to save more people from cancer
• Shop smart at the pharmacy counter
• FDA RECALLS ABBOTT HEART PUMPS LINKED TO DEATHS, INJURIES
• CAN SEA AIR FIGHT CANCER?
• Addressing Accessibil­ity and Affordabil­ity of CELL & GENE THERAPIES
• Growing challenge of medication resistance: Why we need to act now
• Kratom safety bill is a good idea
• Pharmacist shortage limits access to drugs
• Semantics and the pharmaceut­ical industry
• Dubai Health Authority launches post-COVID-19 clinics
• Prescripti­on price hike ‘unbearable’
• UK to reduce overprescr­ibing of medicines
• Addressing Accessibil­ity and Affordabil­ity of CELL & GENE THERAPIES
• Adopting ‘Green Approach’ in Drug Discovery
• Hong Kong invents non-invasive diagnostic device for chronic kidney disease
• Again in Rough Waters?
• Breast cancer survivors in poor areas at higher her risk of new cancer
• CARTI hosts Business After Hours
• Rodgers repeats HIV/AIDS denialism
• Adoption of Alzheimer’s drug slowed
• Cancer treatment adds three years to patients’ lives, trial finds